Experimental oesophagitis in the rat is associated with decreased voluntary movement

Neurogastroenterology and Motility

Volumn 21, Issue 3, 2009, Pages 296-303

  Miwa, H ^a   Oshima, T ^a   Sakurai, J ^a   Tomita, T ^a   Matsumoto, T ^a   Iizuka, S ^b   Koseki, J ^b  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

^b TSUMURA AND CO   (Japan)

Author keywords

Claudin 3; Reflux oesophagitis; Visceral pain; Voluntary movement

Indexed keywords

CLAUDIN 3; OMEPRAZOLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DOSE RESPONSE; ELECTRON MICROSCOPY; EROSION; ESOPHAGUS MUCOSA; INTERCELLULAR SPACE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REFLUX ESOPHAGITIS; VOLUNTARY MOVEMENT; WESTERN BLOTTING;

ANIMALS; ANTI-ULCER AGENTS; DISEASE MODELS, ANIMAL; ESOPHAGITIS, PEPTIC; ESOPHAGUS; MALE; MEMBRANE PROTEINS; MOTOR ACTIVITY; OMEPRAZOLE; RATS; RATS, WISTAR;

EID: 60649118627     PISSN: 13501925     EISSN: 13652982     Source Type: Journal    
DOI: 10.1111/j.1365-2982.2008.01221.x     Document Type: Article

References (34)

1. Dimenas E, Glise H, Hallerback B, Hernqvist H, Svedlund J, Wiklund I. Well-being and gastrointestinal symptoms among patients referred to endoscopy owing to suspected duodenal ulcer. Scand J Gastroenterol 1995 30 : 1046 52.
2. Hongo M, Shoji T. Epidemiology of reflux disease and CLE in East Asia. J Gastroenterol 2003 38 (Suppl. 15 25 30.
3. Chiba N, De Gara CJ, Wilkinson JM, Hunt RH. Speed of healing and symptom relief in grade II to IV gastroesophageal reflux disease: a meta-analysis. Gastroenterology 1997 112 : 1798 810.
4. Richter JE, Campbell DR, Kahrilas PJ, Huang B, Fludas C. Lansoprazole compared with ranitidine for the treatment of nonerosive gastroesophageal reflux disease. Arch Intern Med 2000 160 : 1803 9.
5. Martinez SD, Malagon IB, Garewal HS, Cui H, Fass R. Non-erosive reflux disease (NERD) - acid reflux and symptom patterns. Aliment Pharmacol Ther 2003 17 : 537 45.
6. Venables TL, Newland RD, Patel AC, Hole J, Wilcock C, Turbitt ML. Omeprazole 10 milligrams once daily, omeprazole 20 milligrams once daily, or ranitidine 150 milligrams twice daily, evaluated as initial therapy for the relief of symptoms of gastro-oesophageal reflux disease in general practice. Scand J Gastroenterol 1997 32 : 965 73.
7. Buffington CA. Visceral pain in humans: lessons from animals. Curr Pain Headache Rep 2001 5 : 44 51.
8. Obata K, Yamanaka H, Kobayashi K et al. Role of mitogen-activated protein kinase activation in injured and intact primary afferent neurons for mechanical and heat hypersensitivity after spinal nerve ligation. J Neurosci 2004 24 : 10211 22.
9. Jones RC III., Xu L, Gebhart GF. The mechanosensitivity of mouse colon afferent fibers and their sensitization by inflammatory mediators require transient receptor potential vanilloid 1 and acid-sensing ion channel 3. J Neurosci 2005 25 : 10981 9.
10. Winston J, Shenoy M, Medley D, Naniwadekar A, Pasricha PJ. The vanilloid receptor initiates and maintains colonic hypersensitivity induced by neonatal colon irritation in rats. Gastroenterology 2007 132 : 615 27.
11. Ozaki N, Bielefeldt K, Sengupta JN, Gebhart GF. Models of gastric hyperalgesia in the rat. Am J Physiol Gastrointest Liver Physiol 2002 283 : G666 76.
12. Lamb K, Kang YM, Gebhart GF, Bielefeldt K. Gastric inflammation triggers hypersensitivity to acid in awake rats. Gastroenterology 2003 125 : 1410 8.
13. Banner SE, Sanger GJ. Differences between 5-HT3 receptor antagonists in modulation of visceral hypersensitivity. Br J Pharmacol 1995 114 : 558 62.
14. Tobey NA, Carson JL, Alkiek RA, Orlando RC. Dilated intercellular spaces: a morphological feature of acid reflux - damaged human esophageal epithelium. Gastroenterology 1996 111 : 1200 5.
15. Caviglia R, Ribolsi M, Gentile M et al. Dilated intercellular spaces and acid reflux at the distal and proximal oesophagus in patients with non-erosive gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2007 25 : 629 36.
16. Hopwood D, Milne G, Logan KR. Electron microscopic changes in human oesophageal epithelium in oesophagitis. J Pathol 1979 129 : 161 7.
17. Solcia E, Villani L, Luinetti O et al. Altered intercellular glycoconjugates and dilated intercellular spaces of esophageal epithelium in reflux disease. Virchows Arch 2000 436 : 207 16.
18. Caviglia R, Ribolsi M, Maggiano N et al. Dilated intercellular spaces of esophageal epithelium in nonerosive reflux disease patients with physiological esophageal acid exposure. Am J Gastroenterol 2005 100 : 543 8.
19. Tobey NA, Hosseini SS, Argote CM, Dobrucali AM, Awayda MS, Orlando RC. Dilated intercellular spaces and shunt permeability in nonerosive acid-damaged esophageal epithelium. Am J Gastroenterol 2004 99 : 13 22.
20. Carney CN, Orlando RC, Powell DW, Dotson MM. Morphologic alterations in early acid-induced epithelial injury of the rabbit esophagus. Lab Invest 1981 45 : 198 208.
21. Orlando RC, Powell DW, Carney CN. Pathophysiology of acute acid injury in rabbit esophageal epithelium. J Clin Invest 1981 68 : 286 93.
22. Asaoka D, Miwa H, Hirai S et al. Altered localization and expression of tight-junction proteins in a rat model with chronic acid reflux esophagitis. J Gastroenterol 2005 40 : 781 90.
23. Yoo J, Nichols A, Mammen J et al. Bryostatin-1 enhances barrier function in T84 epithelia through PKC-dependent regulation of tight junction proteins. Am J Physiol Cell Physiol 2003 285 : C300 9.
24. Oshima T, Sasaki M, Kataoka H, Miwa H, Takeuchi T, Joh T. Wip1 protects hydrogen peroxide-induced colonic epithelial barrier dysfunction. Cell Mol Life Sci 2007 64 : 3139 47.
25. Stevenson BR, Goodenough DA. Zonulae occludentes in junctional complex-enriched fractions from mouse liver: preliminary morphological and biochemical characterization. J Cell Biol 1984 98 : 1209 21.
26. Omura N, Kashiwagi H, Chen G, Suzuki Y, Yano F, Aoki T. Establishment of surgically induced chronic acid reflux esophagitis in rats. Scand J Gastroenterol 1999 34 : 948 53.
27. Sakakibara A, Furuse M, Saitou M, Ando-Akatsuka Y, Tsukita S. Possible involvement of phosphorylation of occludin in tight junction formation. J Cell Biol 1997 137 : 1393 401.
28. Talley NJ, Vakil N. Guidelines for the management of dyspepsia. Am J Gastroenterol 2005 100 : 2324 37.
29. Haycox A, Einarson T, Eggleston A. The health economic impact of upper gastrointestinal symptoms in the general population: results from the Domestic/International Gastroenterology Surveillance Study (DIGEST). Scand J Gastroenterol Suppl 1999 231 : 38 47.
30. Tack J, Talley NJ, Camilleri M et al. Functional gastroduodenal disorders. Gastroenterology 2006 130 : 1466 79.
31. Revicki DA, Wood M, Wiklund I, Crawley J. Reliability and validity of the Gastrointestinal Symptom Rating Scale in patients with gastroesophageal reflux disease. Qual Life Res 1998 7 : 75 83.
32. Calvert EL, Houghton LA, Cooper P, Morris J, Whorwell PJ. Long-term improvement in functional dyspepsia using hypnotherapy. Gastroenterology 2002 123 : 1778 85.
33. Locke GR III., Weaver AL, Melton LJ III., Talley NJ. Psychosocial factors are linked to functional gastrointestinal disorders: a population based nested case-control study. Am J Gastroenterol 2004 99 : 350 7.
34. Avidan B, Sonnenberg A, Schnell TG, Sontag SJ. There are no reliable symptoms for erosive oesophagitis and Barrett's oesophagus: endoscopic diagnosis is still essential. Aliment Pharmacol Ther 2002 16 : 735 42.